Summary & Overview
CPT 32560: Chemical Pleurodesis via Chest Tube or Catheter
CPT code 32560 captures bedside chemical pleurodesis performed by instilling a sclerosing agent such as talc into the pleural space through a chest tube or catheter. This code is clinically important for management of recurrent pleural effusions and malignant pleural disease where pleurodesis is indicated to prevent reaccumulation of fluid. Nationally, the code matters for hospital inpatient and procedural billing, clinical documentation of pleurodesis, and for comparisons of procedural utilization related to pleural disease.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service represented by the code, payer coverage context, and what types of benchmarks and policy considerations typically accompany analysis of this procedure. The publication outlines where the service is commonly performed, documentation elements that support use of the code, and the kinds of benchmarking and policy updates that affect reimbursement and utilization tracking.
The report is intended to inform coding professionals, hospital revenue leaders, and clinical stakeholders about the role of CPT code 32560 in pleural disease management, payer coverage landscapes, and the operational settings where the procedure is delivered. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 32560 describes instillation of a chemical agent, such as talc, into the pleural space via an existing chest tube or catheter. This procedure is performed to create pleurodesis by inducing adhesions between the visceral and parietal pleura.
-
Service type: Chemical pleurodesis via chest tube or catheter
-
Typical site of service: Inpatient ward or hospital procedure area where chest tube management and bedside instillation can be performed; may also occur in observation units or procedural suites depending on facility practice
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old man with recurrent malignant pleural effusion from metastatic lung adenocarcinoma who presents with progressive dyspnea and large unilateral pleural fluid on chest radiograph. A chest tube (small-bore pigtail catheter) is placed for drainage and lung re-expansion; after adequate drainage and confirmation of lung expansion, the provider instills a chemical sclerosant such as sterile talc into the pleural space via the existing chest tube to produce pleurodesis and prevent reaccumulation. The workflow includes informed consent, evaluation of anticoagulation status, pre-procedure analgesia and sedation as indicated, sterile preparation and verification of chest tube position, instillation of the talc slurry, monitoring for post-procedure complications (fever, chest pain, hypoxia), chest radiograph or ultrasound follow-up, and documentation of volume instilled, agent used, and patient tolerance. Typical site of service is an inpatient ward or interventional radiology procedure suite, with occasional performance in the hospital observation unit. The service type is a surgical/therapeutic pleural procedure performed through an indwelling chest tube or catheter to induce pleural symphysis.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
52 | Reduced services | Use when talc pleurodesis is partially performed or discontinued before completion due to clinical reasons. |